According to Ries (2014), patients with diffuse-type giant cell tumor, the clinical activity of RG7155 was evaluated and was revealed to induce a striking reduction in the CSF-1R + CD163+ macrophage population within tumor tissues [85]. Here, CD163 is linked to tenosynovial giant cell tumor, diffuse type.